CRBP

Corbus Pharmaceuticals Holding

CRBP.US corbuspharma.com + Research + Basket
CIK 0001595097
Employees 36
Phone 617 963 0100
Fiscal year end December
IPO Nov 11, 2014
Address 500 River Ridge Drive, Norwood, MA, United States, 02062
4.03
+0.04 (+1.00%)
USD · NASDAQ
52-week range
3.87
17.75
Trading at 1% of the 52-week range
Market Cap
77.17M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
5.48
Div. Yield
N/A
% Institutions
83.75%
% Insiders
1.24%

1 Year

-76.5%

3 Year

-23.4%

10 Year

-97.5%
Description

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Actions

Add an action for CRBP.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Yuval Cohen Ph.D. CEO & Director 1975
Mr. Sean F. Moran CPA, M.B.A. Chief Financial Officer 1958
Dr. Ian Hodgson B.Sc., Ph.D. Chief Operating Officer 1973
Mr. G. Scott Goeken J.D., M.S. General Counsel & Corporate Secretary NA
Ms. Christina Bertsch M.A. Vice President of Human Resources NA
Mr. Nishant C. Saxena Chief Business Officer NA
Dr. Leonardo Viana Nicacio M.D. Chief Medical Officer 1978

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Feb 03, 2026 Dominic Smethurst N/A Sale 3.29K $8.09 $26.58K SEC
Feb 03, 2026 Ian Hodgson N/A Sale 2.42K $8.09 $19.54K SEC
Dec 11, 2025 Cormorant Asset Management, Lp N/A Sale 30.03K $11.46 $344.13K SEC
Oct 27, 2025 Yuval Cohen N/A Sale 8.97K $17.14 $153.80K SEC
Oct 24, 2025 Sean F Moran N/A Sale 12.98K $17.02 $220.94K SEC
Oct 24, 2025 Yuval Cohen N/A Sale 18.66K $17.01 $317.41K SEC
Oct 20, 2025 Anne Altmeyer N/A Sale 1.06K $20.50 $21.73K SEC
May 30, 2025 Anne Altmeyer N/A Sale 1.39K $7.25 $10.09K SEC
May 30, 2025 John Kenneth Jenkins N/A Sale 2.78K $7.35 $20.46K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Cormorant Asset Management, LLC 2.34M Jun 30, 2026 12.12% $1.13 0.00%
Orbimed Advisors LLC 1.74M Jun 30, 2026 8.98% $0.30 0.00%
BlackRock Inc 1.33M Jun 30, 2026 6.88% $0.00 390.04%
Aberdeen Group PLC 1.32M Jun 30, 2026 6.83% $0.02 0.00%
Vanguard Capital Management, LLC 760.94K Jun 30, 2026 3.93% $0.00 3.66%
Jones Hill Capital LP 653.57K Jun 30, 2026 3.38% $1.30 0.00%
Prosight Management, LP 650.00K Jun 30, 2026 3.36% $1.05 -6.76%
Stonepine Capital Management Llc 425.00K Jun 30, 2026 2.20% $2.25 10.83%
Geode Capital Management, LLC 423.37K Jun 30, 2026 2.19% $0.00 126.37%
ADAR1 Capital Management LLC 421.79K Jun 30, 2026 2.18% $0.18 27.13%
Diadema Partners LP 301.26K Jun 30, 2026 1.56% $0.36 -31.52%
Susquehanna International Group, LLP 293.20K Jun 30, 2026 1.52% $0.00 -12.06%
State Street Corp 254.67K Jun 30, 2026 1.32% $0.00 269.78%
Dimensional Fund Advisors, Inc. 190.21K Jun 30, 2026 0.98% $0.00 39.25%
Exome Asset Management LLC 184.91K Jun 30, 2026 0.96% $1.07 -21.02%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 151.64K Jun 30, 2026 0.78% $0.00 -5.50%
Jane Street Group LLC 139.13K Jun 30, 2026 0.72% $0.00 90.09%
Northern Trust Corp 124.91K Jun 30, 2026 0.65% $0.00 200.95%
Vanguard Fiduciary Trust Co 112.40K Jun 30, 2026 0.58% $0.00 16.79%
Vanguard Portfolio Management, LLC 111.30K Jun 30, 2026 0.58% $0.00 356.81%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Biotech Growth Ord 538.60K 2.78% ▲ 0.00% Jun 30, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 533.58K 2.76% ▲ 0.00% Sep 30, 2026
3 abrdn Healthcare Investors 434.03K 2.24% ▲ 0.00% Sep 30, 2026
4 iShares Russell 2000 ETF 431.39K 2.23% ▼ 1.14% Sep 30, 2026
5 Fidelity Small Cap Index 179.56K 0.93% ▲ 0.51% Jul 31, 2026
6 Global X Marijuana Life Sciences ETF 173.12K 0.90% ▲ 20.87% Sep 30, 2026
7 iShares Russell 2000 Value ETF 157.90K 0.82% ▲ 0.15% Sep 30, 2026
8 Vanguard Russell 2000 ETF 99.52K 0.51% ▲ 5.09% Sep 30, 2026
9 Fidelity Enhanced Small Cap Core ETF 90.52K 0.47% ▲ 0.21% Sep 30, 2026
10 HealthInvest Sustainable Healthcare E 69.77K 0.36% ▲ 0.00% Dec 31, 2025

Financial Highlights

▼
Market Cap: $77.17M
EBITDA: $-106.68M
PEG Ratio: $0.00
Book Value: $5.48
Earnings/Share: $-6.11
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -53.00%
ROE (TTM): -95.58%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $-36.41M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 19.34M
Shares Float: 13.25M
% Insiders: 1.24%
% Institutions: 83.75%
Short % Float: 18.08%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-233.00K
Gross Profit
subtotal
$-233.00K
SG&A
adjust
$-15.22M
R&D
adjust
$-70.10M
Operating Income
subtotal
$-85.31M
Other / Non-Operating Items
adjust
$6.77M
Net Income
subtotal
$-78.54M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CRBP.US!